skip to main content

IBD mesalazine monitoring — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateGastrointestinal TherapeuticsIBD mesalazine monitoringGPhC CRA

A patient starting mesalazine for ulcerative colitis asks why blood tests are requested despite it being a gut medicine. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Renal function and blood monitoring as advised

Mesalazine can rarely affect renal function and blood parameters. Baseline and periodic monitoring are used to detect toxicity. In this scenario, the correct option is renal function and blood monitoring as advised. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.

Reference: BNF